| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |